Validating Targets in the Brain: Using Imaging to Build Confidence in Therapeutic Potential

• Use brain metastases as a clinical case study to understand target accessibility, engagement, and biodistribution within the challenging brain environment
• Leverage clinical imaging to determine whether a targeting agent can reach and sufficiently accumulate within brain lesions
• Translate lessons from imaging into target-validation criteria for therapeutic development, while accounting for the different requirements of imaging and RLT

Novel Target

Speakers:

Riccardo Canevari

Chief Executive Officer

RadioPharm Theranostics